Malaysia Medical Device Registration Dossier: Requirements for Class B, C & D Medical Devices

Getting a Class B, C or D medical device approved in Malaysia depends heavily on one critical submission — the registration dossier to the Medical Device Authority (MDA). For overseas manufacturers, this is often one of the most time-intensive stages of the registration process, requiring coordination of documentation from multiple sources, including technical files, manufacturer certificates, conformity assessment records, declarations, and other supporting evidence

This guide breaks down the key components of a typical Malaysia Medical Device Registration Dossier and explains how each contributes to a successful submission. For help ensuring your dossier is complete, consistent, and aligned with MDA requirements, contact Cisema today.

What Is Included in a Malaysia Medical Device Registration Dossier?

A Malaysia Medical Device Registration Dossier is the submission package provided to the MDA to support approval of a medical device in Malaysia. It isn’t a single file, but a collection of documents that together show the device is safe, performs as intended, and meets regulatory requirements.

The exact evidence required spans everything from design and manufacturing controls to clinical performance data. While the dossier contents vary based on the device type, risk classification, and chosen regulatory pathway, the underlying goal remains the same: to present an unambiguous, well-supported case for compliance.

When that information is well prepared and internally consistent, the review process tends to be smoother, with fewer follow-up questions from the MDA.

The 8 Core Building Blocks of a Malaysia Medical Device Dossier

To help you navigate this documentation process, the sections below break down the eight core components of a typical Malaysian medical device dossier. What follows is a detailed look at each required section, outlining its structural purpose and what it must contribute to ensure a successful submission to the MDA.

1. Classification & Grouping Strategy: Setting the Regulatory Foundation

Every Malaysia Medical Device Registration Dossier begins by documenting the device's classification under Malaysia's medical device classification rules, as this determines the regulatory requirements that follow.

This includes a clear justification of the classification based on intended use, mode of operation, and risk level. Where multiple products are involved, it must also define the grouping approach — whether the submission covers a single device, family, system, or set — since this directly affects the scope of documentation required.

Selecting the appropriate grouping can significantly reduce both registration costs and administrative effort, while incorrect grouping frequently results in requests for clarification or resubmission by the MDA.

2. Device Identity & Product Description: Defining Your Tech

The registration dossier must clearly identify the medical device and describe its intended purpose. This information establishes the device's identity and provides the foundation for the technical and regulatory documentation that follows.

The information typically consists of:

• Generic and proprietary product names
• Intended purpose and indications for use
• Device category
• Model numbers and variants
• Accessories
• Technical specifications
• Global Medical Device Nomenclature (GMDN) code and other applicable identifiers
• Unique Device Identifier (UDI), where applicable

For combination products containing medicinal or biological components, the dossier may also need to include additional documentation, such as endorsement from Malaysia's National Pharmaceutical Regulatory Agency (NPRA), where applicable.

To avoid delays during review, the product description should remain consistent throughout the dossier, including the Instructions for Use (IFU), labelling, technical documentation and supporting evidence.

3. The CSDT Framework: The Technical Core of Your Application

The Common Submission Dossier Template (CSDT) forms the central technical framework of the dossier, bringing together the evidence that demonstrates the device’s safety and performance.

Rather than being a standalone document, it provides a structured format for presenting technical data in line with Malaysia’s Essential Principles of Safety and Performance.

A typical CSDT includes:

• Executive Summary: An overview of the device, its intended purpose, underlying technology and regulatory history.
• Device Description: Information describing the device design, operating principles, materials, accessories and configurations.
• Essential Principles Checklist: Evidence demonstrating compliance with Malaysia's Essential Principles through applicable standards, testing and risk control measures.
• Design Verification and Validation: Supporting evidence covering performance testing, electrical safety, electromagnetic compatibility, mechanical testing, software verification and validation, sterilization validation (where applicable), and shelf-life studies.
• Biological Safety: Biocompatibility evaluations and supporting testing, typically conducted in accordance with ISO 10993 where relevant.
• Clinical Evidence: Clinical investigations published literature or equivalence data supporting the device's safety and clinical performance.
• Risk Management: Risk analysis and risk control documentation prepared in accordance with ISO 14971.
• Labeling: Copies of product labels, packaging artwork and Instructions for Use (IFU) intended for the Malaysian market.

The CSDT is typically prepared by the local license holder or regulatory representative using technical documentation supplied by the manufacturer before it is incorporated into the overall registration dossier.

4. Supply Chain Transparency: Manufacturer & Site Vetting

The Malaysia medical device registration dossier must identify both the legal manufacturer and every manufacturing site involved in producing the device.

Supporting documentation generally includes:

• Manufacturer name and address
• Manufacturing site details
• ISO 13485 certificates
• Manufacturing licenses, where applicable
• Evidence of outsourced manufacturing arrangements, where relevant

The information provided should remain consistent across all certificates, declarations, and supporting regulatory documentation included in the dossier.

5. Conformity Assessment: Proving Independent Validation

Class B, C, and D devices must undergo conformity assessment by a registered Conformity Assessment Body (CAB) prior to submission.

The dossier therefore includes:

• CAB certificate
• CAB assessment report
• Certificate validity dates
• CAB registration details

The inclusion of these documents confirms that the device has been independently evaluated against Malaysia’s regulatory requirements.

6. Global Leverage: Utilizing Reference Market Approvals

Where a medical device has already been approved by recognized reference authorities, evidence of these approvals should be included in the medical device registration dossier.

Supporting documentation may include:

• Approval certificates
• Registration numbers
• Validity periods
• Regulatory status in the reference market

Including these documents enables the MDA to consider the device's existing regulatory history and, where applicable, determine whether an verification pathway may be appropriate. The final review pathway is determined by the MDA based on the individual application.

7. Regulatory Declarations: Establishing Legal Accountability

Regulatory declarations are a key component of the Malaysia Medical Device Registration Dossier, providing formal confirmation that the device complies with applicable regulatory requirements.

The primary declaration required is the Declaration of Conformity, in which the manufacturer attests that the medical device meets the relevant requirements of the Medical Device Authority (MDA), including compliance with applicable standards and the Essential Principles of Safety and Performance.

The Declaration of Conformity should be completed using the prescribed MDA format and signed by an authorized representative of the manufacturer before the registration dossier is submitted.

8. Post-Market Safety Data: Demonstrating Real-World Reliability

As part of the Malaysia Medical Device Registration Dossier, manufacturers are required to disclose relevant post-market safety information to the MDA relating to the device.

This may include:

• Previous recalls
• Safety notices
• Regulatory restrictions
• Adverse event history
• Ongoing post-market clinical follow-up, where applicable

Providing complete and transparent post-market safety information enables the MDA to assess the device's regulatory history as part of the registration review.

Overcoming Common Malaysia Medical Device Registration Dossier Pitfalls

Preparing a Class B, C, or D registration dossier is rarely straightforward. Many applications are delayed not because of missing documents, but because of inconsistencies, incomplete evidence, or avoidable oversights within the dossier itself.

Below are some of the most common challenges manufacturers face, along with practical ways to address them before submission.

By identifying and addressing these common pitfalls early, manufacturers can significantly improve the quality of their registration dossier and reduce the likelihood of delays during MDA review.

Final Thoughts: Securing a Smooth Path to the Malaysian Market

A well-prepared registration dossier forms the foundation of a successful Class B, C and D medical device registration in Malaysia. By ensuring the dossier is complete, accurate and consistent before submission, manufacturers can help minimize requests for additional information and reduce avoidable delays during the MDA's review.

For manufacturers entering the Malaysian market, Cisema supports the process end-to-end — from early-stage classification and grouping decisions through to acting as an independent license holder, handling submissions via MeDC@St, and managing ongoing post-registration obligations.

Get in touch with Cisema today to secure your medical device approvals and launch in Malaysia with confidence.

About the Author: Shouzheng Tan

Shouzheng Tan is Vice President of Southeast Asia at Cisema, based in Penang, Malaysia. He brings more than a decade of experience in the medical device industry, specializing in regulatory registration and market access across Southeast Asia. In his role, he works closely with overseas manufacturers to develop and implement effective regulatory strategies for medical devices throughout the region, including key markets such as Malaysia. His expertise is complemented by working knowledge of quality management systems, allowing him to support clients across both regulatory and compliance requirements.

Further Information

• Explore Cisema’s services for medical device registration in Malaysia.

References

• Medical Device Act 2012 (Act 737)

‍